The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

After a series of bumps in the road, Roviant and Priovant Therapeutics have finally secured US approval for the once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for adults with ...

While obesity may be a fast-growing cost area, it's far from the largest -- only 10% of employers surveyed put it in their ...

The ambition to build a Phase I oncology clinical development centre can be deceptively simple. The temptation is to ...

AstraZeneca and Amgen have announced the first Phase III results for Tezspire (tezepelumab) in eosinophilic oesophagitis (EoE ...

The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference will explore how pharma ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...